The University of Toronto has acquired four floors in the new west tower of MaRS and will be taking a 20 per cent equity share in the building.
“This is a big step in our overall commitment to support our students, faculty and researchers in their work solving the most complex and devastating diseases of our time,” says Scott Mabury, Professor & Vice-President of Operations for the University of Toronto.
Continue reading at UofT News.